[Press Release] Himeji City Becomes the First Government Body to Join AMR Alliance Japan – Following the 72nd Session of the World Health Organization Regional Committee for the Western Pacific, held in Himeji City, the City Government announced its participation in AMR Alliance Japan (November 17, 2021)
date : 11/17/2021
Tags: AMR
Himeji City announced its intention to join AMR Alliance Japan during a press conference held after the 72nd session of the World Health Organization Regional Committee for the Western Pacific (held in Himeji City from November 25 to November 29, 2021). The announcement makes Himeji City the first Government body to join the Alliance. Hideyasu Kiyomoto, the Mayor of Himeji City commented that Himeji City was going to consider serious steps to tackle the problem of AMR.
On September 25, 2021, prior to the World Health Organization Regional Committee for the Western Pacific, AMR Alliance Japan, Himeji City, Himeji Medical Association, and Himeji Dental Association hosted an official related event, “AMR: A Global Health Crisis -What We Can Do for the Fight Against the Silent Pandemic of AMR: Learning from COVID-19.” This event was supported by Ministry of Health, Labour and Welfare, Himeji Pharmacist Association and Hyogo Nursing Association Seiban Branch, and sponsored by Japan Pharmaceutical Manufacturers Association. The event stressed the urgency of AMR as a worldwide health crisis, and called for policy action at the global and local level.
Together with Himeji City and all of its members, AMR Alliance Japan will continue to promote the creation of stronger countermeasures against AMR through broad-based multisector collaboration.
■About AMR Alliance Japan AMR
AMR Alliance Japan was established in November 2018 as multi-stakeholder, collaborative organization dedicated to the improvement of public health through the promotion of AMR countermeasures. As of November 2021, its members include, in alphabetical order: Himeji City; The Japanese Association for Infectious Diseases; The Japanese Society for Chemotherapy; The Japanese Society for Clinical Microbiology; The Japanese Society for Medical Mycology; The Japanese Society for Pediatric Infectious Diseases; The Japanese Society of Infection Prevention and Control; The Japanese Society of Pharmaceutical Health Care and Sciences; The Japanese Society of Therapeutic Drug Monitoring; The Japan Medical Association; The Japan Pharmaceutical Association; The Japan Pharmaceutical Manufacturers Association; The Japan Society of Hospital Pharmacists; “Kodomo to Iryo” Project; MSD K.K.; Nippon Becton Dickinson Co., Ltd.; Pfizer Inc.; The Pharmaceutical Society of Japan; Shionogi & Co., Ltd. The Health and Global Policy Institute serves as the Secretariat of AMR Alliance Japan. Please scan the QR code at right to see our AMR Alliance Japan Website.
■Spreading Awareness about AMR in the Month of November
In Japan, the Cabinet Secretariat has designated November as “Antimicrobial Resistance (AMR) Awareness Month.” This aligns with “World Antimicrobial Awareness Week(WAAW),” which has been set for November 18 to November 24 this year by the WHO. This year’s theme is “Spread Awareness, Stop Resistance.”
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)